Valence Discovery

formerly Valence LabsAcquired

AI drug discovery with graph neural networks

Montréal, Canada · Founded 2018 · $25.0M raised

Headquarters
Montréal
Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$25.0M
Last Round
Series BSep 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Montreal-based AI drug discovery company (acquired by Recursion Pharmaceuticals in May 2023 for $47.5M USD). Valence Labs, the rebranded research engine, develops graph neural network (GNN) foundation models for molecular property prediction and drug discovery. The company built MolGPS, a 3-billion parameter GNN model trained on 5+ million molecules, achieving state-of-the-art performance on ADMET (absorption, distribution, metabolism, excretion, toxicity), binding prediction, and molecular design benchmarks.

Summary

Valence Discovery is an Artificial Intelligence company based in Montréal, Canada, founded in 2018. It has raised $25.0M in total across 4 rounds, most recently a Series B round in Sep 2025. Investors include Insight Partners, Bessemer Venture Partners and Air Street Capital.

Tech & App Stack

15 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025

Sign up to see all 4 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Valence Discovery on Indexed.vc
<a href="https://indexed.vc/companies/valence-discovery"><img src="https://indexed.vc/api/badge/company/valence-discovery" alt="Valence Discovery on Indexed.vc" width="260" height="76" /></a>